Editorial: Impact of system biology and molecular medicine on the management of complex immune mediated respiratory diseases, volume II

Blanca Cárdaba; Girolamo Pelaia

doi:10.3389/fmed.2023.1187941

Editorial: Impact of system biology and molecular medicine on the management of complex immune mediated respiratory diseases, volume II

Front Med (Lausanne). 2023 Jun 7:10:1187941. doi: 10.3389/fmed.2023.1187941. eCollection 2023.

Authors

Blanca Cárdaba^{1

2}, Girolamo Pelaia³

Affiliations

¹ Immunology Department, IIS-Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Madrid, Spain.
² Center for Biomedical Network of Respiratory Diseases (CIBERES), ISCIII, Madrid, Spain.
³ Department of Health Sciences, University "Magna Græcia" of Catanzaro, Catanzaro, Italy.

No abstract available

Keywords: COVID; asthma; biological therapies asthma; chronic obstructive pulmonary disease; metabolomic; miRNA; respiratory inflammation.

Publication types

Editorial

Grants and funding

This work was supported by research grant PI20/00903 cofunded by FEDER, CIBERES (ISCIII, 0013), and RETIC (RD09/0076/00101) from the Fondo de Investigación Sanitaria (Ministerio de Sanidad y Consumo, Spain).